Avicanna Inc. AVCN.TO Stock
Avicanna Inc. Price Chart
Avicanna Inc. AVCN.TO Financial and Trading Overview
Avicanna Inc. stock price | 0.4 CAD |
Previous Close | 0.28 CAD |
Open | 0.27 CAD |
Bid | 0.31 CAD x N/A |
Ask | 0.32 CAD x N/A |
Day's Range | 0.27 - 0.31 CAD |
52 Week Range | 0.2 - 0.56 CAD |
Volume | 31.7K CAD |
Avg. Volume | 69.98K CAD |
Market Cap | 25.79M CAD |
Beta (5Y Monthly) | 1.799566 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1 CAD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.7 CAD |
AVCN.TO Valuation Measures
Enterprise Value | 31.1M CAD |
Trailing P/E | N/A |
Forward P/E | -5.166667 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.1700196 |
Price/Book (mrq) | 22.142857 |
Enterprise Value/Revenue | 7.439 |
Enterprise Value/EBITDA | -2.675 |
Trading Information
Avicanna Inc. Stock Price History
Beta (5Y Monthly) | 1.799566 |
52-Week Change | 34.78% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.56 CAD |
52 Week Low | 0.2 CAD |
50-Day Moving Average | 0.38 CAD |
200-Day Moving Average | 0.37 CAD |
AVCN.TO Share Statistics
Avg. Volume (3 month) | 69.98K CAD |
Avg. Daily Volume (10-Days) | 19.7K CAD |
Shares Outstanding | 83.2M |
Float | 69.83M |
Short Ratio | 0.3 |
% Held by Insiders | 20.73% |
% Held by Institutions | 0% |
Shares Short | 33.13K |
Short % of Float | N/A |
Short % of Shares Outstanding | 0.040% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -289.95% |
Gross Margin | -2.32% |
EBITDA Margin | -278.11% |
Management Effectiveness
Return on Assets (ttm) | -34.32% |
Return on Equity (ttm) | -213.20% |
Income Statement
Revenue (ttm) | 4.18M CAD |
Revenue Per Share (ttm) | 0.06 CAD |
Quarterly Revenue Growth (yoy) | 12.69% |
Gross Profit (ttm) | 1.12M CAD |
EBITDA | -11625777 CAD |
Net Income Avi to Common (ttm) | -16304570 CAD |
Diluted EPS (ttm) | -0.28 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 221.88K CAD |
Total Cash Per Share (mrq) | 0.003 CAD |
Total Debt (mrq) | 1.81M CAD |
Total Debt/Equity (mrq) | 36.96 CAD |
Current Ratio (mrq) | 0.674 |
Book Value Per Share (mrq) | 0.014 |
Cash Flow Statement
Operating Cash Flow (ttm) | -6345335 CAD |
Levered Free Cash Flow (ttm) | -5162969 CAD |
Profile of Avicanna Inc.
Country | Canada |
State | ON |
City | Toronto |
Address | 480 University Avenue |
ZIP | M5G 1V2 |
Phone | N/A |
Website | https://www.avicanna.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 80 |
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development that leads to the commercialization of approximately twenty products across four main market segments. The company provides medical and wellness products containing cannabidiol, cannabigerol, and tetrahydrocannabinol under the RHO Phyto brand; functional CBD consumer derma-cosmetic and topical products under the Pura H&W and Pura Earth brand names; and cannabis dried flowers, standardized seeds, full spectrum extracts, cannabinoid distillates, isolated cannabinoids, and bulk formulations derived from hemp and cannabis cultivars under the Aureus brand. It also develops pharmaceutical products for epidermolysis bullosa, dermatology, chronic pain, and various neurological disorders. The company has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based treatment for lung inflammation associated with COVID19. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.
Q&A For Avicanna Inc. Stock
What is a current AVCN.TO stock price?
Avicanna Inc. AVCN.TO stock price today per share is 0.4 CAD.
How to purchase Avicanna Inc. stock?
You can buy AVCN.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Avicanna Inc.?
The stock symbol or ticker of Avicanna Inc. is AVCN.TO.
Which industry does the Avicanna Inc. company belong to?
The Avicanna Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Avicanna Inc. have in circulation?
The max supply of Avicanna Inc. shares is 92.29M.
What is Avicanna Inc. Price to Earnings Ratio (PE Ratio)?
Avicanna Inc. PE Ratio is now.
What was Avicanna Inc. earnings per share over the trailing 12 months (TTM)?
Avicanna Inc. EPS is -0.1 CAD over the trailing 12 months.
Which sector does the Avicanna Inc. company belong to?
The Avicanna Inc. sector is Healthcare.